Friday 6 November 2026
Export KIDS’s income statement to Excel — free account
OrthoPediatrics Corp.
KIDS Healthcare Medical Devices
OrthoPediatrics Corp.’s revenue for fiscal 2025 (year ended December 2025) was $236.3 million, up 15.4% from fiscal 2024.
- Revenue
- +18.6%
- EPS
- +50.9%
- Free cash flow
- +146.6%
- Total debt
- +0.99%
Quarter to September 2026, against a year earlier
31.95
0.27
−0.84%
Follow KIDS
Alert me
OrthoPediatrics Corp. (KIDS) P/E ratio
OrthoPediatrics Corp. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 1,244× (February 2023) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 1,024× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 0.0× | — |
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| 36 more quarters | Free account |
Against its own ten years
Low 0.0×
High 1,244×
Ten-year median
0.0×
Current reading's percentile
89
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| PACB Pacific Biosciences of California, Inc. compare | n/m |
| CTKB Cytek Biosciences, Inc. compare | n/m |
| BBNX Beta Bionics, Inc. compare | n/m |
| AHCO AdaptHealth Corp. compare | n/m |
| QDEL QuidelOrtho Corporation compare | n/m |
| KIDS OrthoPediatrics Corp. | n/m |
| INMD InMode Ltd. compare | 10.7× |
| BVS Bioventus Inc. compare | 12.3× |
| VREX VAREX IMAGING compare | 34.8× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)